|
Volumn 29, Issue 10, 2008, Pages 1336-1337
|
Why must new cardiovascular risk factors be carefully re-assessed prior to clinical application?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
BRAIN NATRIURETIC PEPTIDE;
TROPONIN;
CARDIOVASCULAR RISK;
CAUSAL ATTRIBUTION;
CLINICAL PRACTICE;
HUMAN;
LETTER;
LONGITUDINAL STUDY;
MICROALBUMINURIA;
MORBIDITY;
MORTALITY;
PREDICTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
STATISTICAL ANALYSIS;
CARDIOVASCULAR DISEASES;
EPIDEMIOLOGIC METHODS;
HUMANS;
|
EID: 44449162621
PISSN: 0195668X
EISSN: 15229645
Source Type: Journal
DOI: 10.1093/eurheartj/ehn151 Document Type: Letter |
Times cited : (4)
|
References (6)
|